Impact of ETI Therapy on Chronic Inhaled Medication Refill Rates in Cystic Fibrosis
Yayımlayan：Unknown
·Yayın tarihi: 2025-12-13
A discussion exploring how the introduction of elexacaftor/tezacaftor/ivacaftor (ETI) therapy influences prescription refill rates for chronic inhaled medications among individuals diagnosed with cystic fibrosis.
Yükleniyor...